glp-1 receptor agonist pancreatitis risk meta-analysis Glucagon-like peptide-1 agonists and pancreatic cancer: a meta- analysis with trial sequential analysis GLP-1 receptor agonists review and
Description
Mechanisms involved in this process are both central and peripheral
doi: 10.1161/CIRCULATIONAHA.112.091215 39 GuoZQiWYuYDuSWuJLiuJ
Specific trials about the impact of GLP-1 RAs treatment on the risk of HCC incidence or recurrence are currently lacking
The case raises a question that researchers are now actively investigating
Similarity, pooled results found that GLP-1RAs increased nausea (OR: 4.41, 95% CI: 2.98, 6.55
doi: 10.1210/jc.2005-1093 [DOI] [PubMed] [Google Scholar] 122
